Pyxis Oncology, Inc.

• Enterprise value to EBITDA forward of Pyxis Oncology, Inc. – BOATS:PYXS
  TradingView · 22 Oct 2026
• Pyxis Oncology: Better Runway Is Bullish For MICVO’s Remaining R&D (NASDAQ:PYXS)
  Seeking Alpha · 04 Oct 2026
• Pyxis Oncology advances MICVO cancer drug with promising early data and strong financing for Phase 3 trials
  Pluang · 04 Oct 2026
• Pyxis Oncology (PYXS) Slips 2.28% to $2.14 as Shares Test Lower End of Recent Range - VOLD Alert
  https://www.siam.in/ · 03 Oct 2026
• GordonMD global investments acquires Pyxis Oncology common stock By Investing.com
  Investing.com · 02 Oct 2026
• Form 4 Pyxis Oncology Inc For: 2 October By Investing.com
  Investing.com UK · 02 Oct 2026
• Pyxis Oncology Raises $102.8 Million Net in Underwritten Equity Offering Led by Leerink, Guggenheim, Wells Fargo
  TradingView · 01 Oct 2026
• Latham Advises on Pyxis Oncology’s Up to US$282.6 Million Public Offering
  Latham & Watkins LLP · 30 Sep 2026
• Pyxis Oncology prices public offering expected to raise ~$110 million
  The Pharma Letter · 30 Sep 2026
• Pyxis Oncology Prices Public Offering of Common Stock, Warrants
  marketscreener.com · 30 Sep 2026
• Pyxis Oncology shares slide after pricing $110M registered public offering
  TradingView · 29 Sep 2026
• Pyxis Oncology Announces Proposed Public Offering
  GlobeNewswire · 29 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →